Industry, Business & Agriculture Timetable

Industry, Business & Agriculture Timetable

Monday, March 14

10:00 – 10:15

OPENING SESSION

10:15 – 11:00

Chair: Dr. Yuval (Tuby) Zolotov, Ben Gurion University of the Negev, Israel

Dr. Staci Gruber, McLean Hospital; Harvard Medical School, USA

11:30 – 12:00

Moderator: Prof. Mike Barnes, The Medical Cannabis Clinicians Society (MCCS), UK 

Prof. Raphael Mechoulam, The Hebrew University of Jerusalem, Israel

12:00 – 13:15

INNOVATIVE TECHNOLOGIES FOR THE MEDICAL CANNABIS SUPPLY CHAIN  

12:00-12:20
THE FUTURE OF MEDICAL CANNABIS CULTIVATION 
Mr. Tony LeviTrichome LTDIsrael 

12:20-12:40
BEYOND SEED TO SALE USING TECHNOLOGY TO MEET COMPLIANCE AND GROW SALES 
Mr. Bradley Moore, CEO, Global Cannabis Applications Corp, USA

12:40-13:00
INNOVATIVE DELIVERY METHODS FOR MEDICAL CANNABIS 
Dr. Joshua (Shuki) AviramSyqe Medical, Israel 

13:00-13:15
Q&A

14:30 – 15:30

SESSION: EMERGING EUROPEAN MARKETS

Chair: Hannah Simon, Sana Healthcare, UK

Each slot includes 15 min for presentation + 5 min Q&A

14:30 – 14:50
UK  
THE FLEDGLING UK MARKET FOR MEDICAL CANNABIS….IS IT SIMPLY A MATTER OF TIME OR IS THERE SOMETHING DEEPER? 
Hannah Simon, Sana Healthcare, UK 
Prof. Mike Barnes, The Medical Cannabis Clinicians Society (MCCS), UK 

14:50 – 15:10
WHY PORTUGAL MAY BE THE IDEAL HUB FOR MEDICAL CANNABIS IN EUROPE? 
Filomena Frazão AguiarWiseHSPortugal 

15:10 – 15:30
MEDICAL CANNABIS IN DENMARK: LATEST UPDATES
Peter IsraelDanIsCannDenmark 

15:00 – 15:30

SCI TRACK: ORIGINAL STUDIES: RAPID PRESENTATIONS PART II

Chair: Dr. Noa Raz, Bazelet Medical Cannabis Group, Israel

Each slot includes 5 min for presentation + 2 min Q&A

15:00 – 15:02
Introduction

15:02 – 15:09
ADHERENCE, SAFETY AND EFFECTIVENESS OF MEDICAL CANNABIS AND EPIDEMIOLOGICAL CHARACTERISTICS OF THE PATIENT POPULATION: A PROSPECTIVE STUDY 
Lihi SchleiderTikun-Olam Cannabit PharmaceuticalsIsrael 

15:09 – 15:16
FEMALES REPORT MORE ADVERSE EVENTS AND HIGHER NEGATIVE SUBJECTIVE EFFECTS IN MULTIPLE-DOSE TRIALS OF TWO ORAL MEDICAL CANNABIS PRODUCTS 
Dr. Erica PetersCanopy Growth CorporationCanada

15:16 – 15:23
EFFECT OF A CANNABIS EXTRACT ON ACUTE PAIN AND ON ANALGESICS REQUIREMENTS: A DOUBLE-BLINDED, RANDOMIZED, 24 HOURS FOLLOW-UP STUDY 
Dr. Noa RazBazelet Medical Cannabis Group, Israel

15:23 – 15:30
PRE-CLINICAL TOXICITY OF CANNBIGEROL IN RATS AND C. ELEGANS 
Tim Lefever, Canopy Growth, Canada

16:00 – 17:30

PLENARY SESSION: PROMINENT CLINICAL CONCERNS

Chair: Dr. Jeffrey Hergenrather, Society of Cannabis Clinicians, USA 

16:00 – 16:20
CANNABIS IN INTEGRATIVE MEDICINE
Dr. Jeffrey Hergenrather, Society of Cannabis Clinicians, USA

16:20 – 16:40
MEDICAL CANNABIS FOR OLDER ADULTS
Dr. Mikhail KoganGW Center for Integrative Medicine, USA

16:40 – 17:00
CANNABINOID HYPEREMESIS SYNDROME
Dr. Ethan Russo, Member, Cannabis Expert Panel, USA

17:00 – 17:20
EVALUATING PATIENTS AND MONITORING LONG-TERM TREATMENTS WITH CANNABIS AND CANNABINOIDS
Dr. Alan Shackelford, Member, Cannabinoid Research Initiative of Saskatchewan, University of Saskatchewan, USA

17:20 – 17:30 
Q&A 

Tuesday, March 15

09:30 – 10:30

09:30-09:50
TBC
Ben Harpazi, Biodata, Israel

09:50-10:10
NEUROPROTECTIVE EFFECTS OF CANNABIDIOL IN AN ANIMAL MODEL OF PARKINSON’S DISEASE
Claudio Giuliano, IRCCS Mondino Foundation, Pavia, Italy

10:10-10:30
TBC

11:00 – 12:00

Each slot includes 15 min for presentation + 5 min Q&A

11:00 – 11:20
DOSE INHALERS DEVICES: REVOLUTIONISING MEDICAL CANNABIS DRUG DELIVERY 
Jacqueline GreenH&TPresspart, UK

11:20 – 11:40
CANNABIS GENETICS: FROM SEED TO PRODUCT 
Dr. Arnon Heyman, Canonic, Israel

11:40 – 12:00
TBC

12:00 – 12:45

THE CHALLENGES IN BRIDGING THE GAP BETWEEN TRADITIONAL AND MODERN MEDICINE IN THE MEDICAL CANNABIS ARENA

Chair: Dr. Yuval Zolotov

Prof. David (Dedi) Meiri, Technion Israel Institute of Technology, Israel

13:45 – 14:45

CONTROLLED AND RAPID DRYING OF MEDICAL CANNABIS INFLORESCENCES BY RADIO FREQUENCY METHOD 
Looz Milay, CannaSoul Analytics, Israel

VEGETATIVE PROPAGATION EXPERIMENTS ON MEDICINAL CANNABIS (CANNABIS SATIVA L.) 
Sonny Moerenhout, Cultivators, The Netherlands

PRODUCTIVITY EFFECTS OF THREE SINGLE PLANT GROWTH PROMOTING RHIZOBACTERIA INOCULATION ON CANNABIS SATIVA L. GROWTH AND FLOWER YIELD AND CANNABINOIDS PROFILE
Dongmei Lyu, McGill University, Canada

UTILIZATION OF BENEFICIAL AND HIGHLY-EFFICACIOUS PHYTOMICROBIOME TECHNOLOGIES EFFECTS IN PRODUCTION OF CANNABIS SATIVA
Prof. Donald Smith, McGill University, Canada

EVIDENCE-BASED CUSTOMER DISCOVERY AS A FIRST STEP FOR DEVELOPING A DECENTRALIZED CLINICAL RESEARCH PLATFORM FOR MEDICAL CANNABIS 
Dr. Cheryl Fitzer-AttasClinMed LLCUSA

14:45 – 15:45

Each slot includes 15 min for presentation + 5 min Q&A

14:45 – 15:05
TBC

15:05 – 15:25
PERSONALISED MEDICINE USING DNA AS A TOOL FOR COMBINING CANNABINOID THERAPIES IN WELLNESS 
Clare NavasThe Leaf Elite Cannabis Clinic, Spain

15:25 – 15:45
CANOPY GROWTH: A LEADER IN CANNABINOID R&D 
Dr. Marcel Bonn-Miller, Canopy Growth Corporation, Canada

16:15 – 17:15

SESSION: EMERGING BUSINESS TRENDS IN ISRAEL AND WORLDWIDE

16:15 – 16:35
THE REALITY OF THE MEDICAL CANNABIS MARKET IN ISRAEL 
Mr. Saul Kaye, Israel

16:35-16:55
TBC

16:55-17:15
TBC

17:15 – 18:30

PLENARY SESSION: FROM PLANT TO BEDSIDE: EMERGING DISCOVERIES

Chair: Dr. Nirit Bernstein, Volcani Center, Israel

17:15 – 17:35
SCIENCE-BASED CULTIVATION TECHNOLOGIES FOR CANNABIS PRODUCTION
Dr. Nirit Bernstein, Volcani Center, Israel

17:35 – 17:55
DEVELOPING A REAL-WORLD EVIDENCE BASE FOR PRESCRIBED CANNABIS IN THE UNITED KINGDOM: FINDINGS FROM PROJECT TWENTY21 
Dr. Anne Katrin Schlag, Head of ResearchDrug ScienceImperial College London, UK 

17:55 – 18:15
CANNABIS SAFETY UPDATES: IMPAIRMENT, OPIOIDS & PATIENT COMPLEXITIES
Dr. Caroline MacCallum, Faculty of Medicine, University of British Columbia, Canada

18:15 – 18:30
Q&A

* could be subject to change